Rochester NH, May 18, 2015 — Phase 2 Medical Manufacturing, Inc. (, a leading medical device contract manufacturing company, announced today that both of its medical manufacturing facilities received no comments in recent ISO 13485 audits.

The ISO 13485 audit was performed at Phase 2’s Rochester, N.H, medical device contract manufacturing facility in February 2015, and in the Tijuana, Mexico facility in March 2015. You can download a copy of Phase 2’s ISO 13485 certifications here:

ISO 13485 is an International Organization for Standardization (ISO) standard, published in 2003, that represents the requirements for a comprehensive quality management system for the design and manufacture of medical devices. Phase 2 Medical Device Manufacturing is committed to a thorough approach to quality that includes proactive quality assurance initiatives and the ongoing review of every aspect of the company’s medical device contract manufacturing operations. External and internal quality systems are continually improved and updated to conform to the latest medical device contract manufacturing standards and regulations, and to ensure that the products the company develops for the world’s largest medical device manufacturers meet the highest regulatory and performance standards.

To learn more about Phase 2 Medical and medical device contract manufacturing, visit

About Phase 2
Phase 2 Medical Device Manufacturing offers complete outsourcing services for medical device manufacturers. Phase 2 Medical specializes in medical device development, medical device engineering and medical device assembly including medical packaging for medical device manufacturers of all sizes, from innovative startups to large OEMs. Phase 2 is a metrics driven company utilizing sophisticated processes, including LEAN manufacturing, to build single-use medical devices and provide medical device manufacturing solutions to its client partners. For more information, visit